Frontlight ResearchEarly access
Trial site
Multiprofile Hospital For Active Treatment Dr. Hristo Stambolski EOOD
- 5running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Depression5 trials
- Schizophrenia5 trials
- Bipolar disorder3 trials
- Phase
- Phase 25 trials
- Phase 35 trials
- Phase 41 trial
- Status
- Completed4 trials
- Recruiting4 trials
- Suspended2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Xenon Pharmaceuticals Inc.2 trials
- Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Enunciabile Anche Angelini Pharma Italia S.p.A. Angelini Pharma S.p.A. A.C.R.A.F. S.p.A. Acraf S.p.A. Angelini S.p.A. aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.1 trial
- Draig Therapeutics Limited1 trial
- HMNC Holding GmbH1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
Evaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Schizophrenia3 recruiting
- Depression2 recruiting
Closed trials
Completed
A study to assess the efficacy and safety of lumateperone in patients with Bipolar Mania
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 12 Nov 2026